Date: 9 November 2026

Background

The document pertains to the Scheme of Amalgamation between Quality Care India Limited (Transferor Company) and Aster DM Healthcare Limited (now Aster DM Quality Care Limited) (Transferee Company) and their respective shareholders and creditors, approved and sanctioned by the Hon'ble National Company Law Tribunal, Hyderabad Bench vide its Order dated 19 June 2026. The certified copy was received on 22 June 2026.

After fulfilling all conditions specified in Clause 24 (Conditions Precedent to Effectiveness) of the Scheme, both companies filed certified copies of the Order and Scheme in Form INC-28 with the Registrar of Companies, Hyderabad on 26 June 2026. Consequently, Quality Care India Limited stands amalgamated into Aster DM Quality Care Limited and dissolved without winding up as of 1 July 2026, with the Appointed Date being the same as the Effective Date.

On 13 July 2026, the company approved allotment of 35,35,51,410 equity shares of face value ₹10 each to eligible equity shareholders of Quality Care India Limited as on Record Date (9 July 2026). This included 65 equity shares (fractional shares) arising from consolidation of fractional share entitlements, allotted in the name of CTL Trusteeship Limited as trustee.

Fractional Share Treatment

In accordance with the Scheme and SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated 20 June 2023, the 65 fractional shares were sold in the open market within 90 days from allotment date. The shares were sold through the National Stock Exchange of India Limited (NSE) on 8 October 2026 at an average sale price of ₹676.0669 per share.

Sale Details:

  • Number of consolidated fractional shares sold: 65 equity shares
  • Stock exchange: National Stock Exchange of India Limited (NSE)
  • Date of sale: 8 October 2026
  • Average sale price per share: ₹676.0669
  • Gross sale proceeds: ₹43,944.35
  • Less: Statutory/brokerage and transaction charges: ₹65.92
  • Net sale proceeds available for distribution: ₹43,834.43

The process for distribution of net sale proceeds to eligible shareholders was undertaken on 3 November 2026.

Outstanding Amount

Out of the net sale proceeds of ₹43,834.43, an amount aggregating ₹1,886.45 pertaining to 8 eligible shareholder(s) could not be remitted. This amount continues to be held by the company on behalf of the concerned shareholders and shall be dealt with in accordance with applicable provisions of law. The company will continue taking appropriate steps for facilitating payment to these shareholders.

Certification

The Audit Committee and Independent Directors of the company have certified that net proceeds from the sale of consolidated fractional entitlements have been distributed to eligible shareholders in proportion to their respective fractional entitlements, in accordance with the Scheme and applicable SEBI requirements, except for the aggregate amount of ₹1,886.45 relating to 8 shareholders which could not be successfully remitted/credited.